On December 20, the kick-off meeting of "National Key Laboratory for R&D of New Vaccines for New Emerging Infectious Diseases" and the first meeting of the first Academic Committee were held at Sinopharm China Biologicals. Deng Jindong, Vice General Manager of Sinopharm and Chairman of China Bio, and Yang Xiaoming, Chief Scientist and Chief Engineer of Sinopharm, Chief Scientist of China Bio, and Director of the National Key Laboratory for R&D of Novel Vaccines for Newly Emerging Infectious Diseases, formally launched the "National Key Laboratory for R&D of Novel Vaccines for Newly Emerging Infectious Diseases". Academician Zhao Jia, Academician Chen Xiangmei, Academician Li Zaikun, and Academician Wang Junzhi of the Chinese Academy of Engineering attended the launching meeting.

After the launching meeting, the National Key Laboratory of New Vaccine Development for Emerging Infectious Diseases held the first meeting of the first academic committee. The Academic Committee listened to and passed the "All-weight Laboratory Construction Program" by Director Yang Xiaoming. Academician Zhao armor, Academician Chen Xiangmei, Academician Li Zaikun, Academician Wang Junzhi and other attending members gave constructive comments and suggestions on the future development and planning of the National Key Laboratory.

According to the experts, Liu Dengfeng, Inspector of the Department of Science and Education of the National Health Commission, said that the National Key Laboratory for the Research and Development of Novel Vaccines for New Outbreaks of Infectious Diseases is of great significance to scientific and technological innovations in the field of health, the development of the bio-economy, and scientific and technological self-reliance and self-empowerment. Sinopharm China Biological is an active participant in the two major special projects of the Health Commission on the creation of new drugs and the prevention and control of major infectious diseases, and has made important contributions to the prevention and control of epidemics. It is hoped that the national key laboratories will, firstly, continue to strengthen the capacity building, bear the national mission and enrich the scientific and technological connotation of the national key laboratories; secondly, give full play to the advantages of the innovation chain of the relying units, and coordinate the layout of the industrial chain and the innovation chain; thirdly, focus on the major needs of the country and produce significant results; fourthly, strive to create a favorable environment to stimulate scientific and technological innovation, and make new and greater contributions to the prevention and control of the new sudden outbreaks of infectious diseases in China.

https://mp.weixin.qq.com/s/e6RaYu-hbIyLfkzOA4Mmdg